T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
Clinical trial NCT05141058 · RECRUITING
Trial details
- NCT number
- NCT05141058
- Sponsor
- Children's National Research Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2028-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.